Ilyang Pharmaceutical Co.,Ltd
007575.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
202
Cost of Revenue
118
Gross Profit
84
Gross Margin
41.5%
Operating Income
8
Operating Margin
4.1%
Net Income
8
Net Margin
3.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
19
EBITDA Margin
9.3%
2023
12/31/2023
Revenue
278
Cost of Revenue
128
Gross Profit
150
Gross Margin
54.0%
Operating Income
19
Operating Margin
6.7%
Net Income
-2
Net Margin
-0.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
11
EBITDA Margin
4.1%
2022
12/31/2022
Revenue
288
Cost of Revenue
126
Gross Profit
162
Gross Margin
56.3%
Operating Income
30
Operating Margin
10.5%
Net Income
15
Net Margin
5.1%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
39
EBITDA Margin
13.5%
2021
12/31/2021
Revenue
279
Cost of Revenue
125
Gross Profit
153
Gross Margin
55.0%
Operating Income
31
Operating Margin
11.0%
Net Income
11
Net Margin
3.8%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
36
EBITDA Margin
13.0%
2020
12/31/2020
Revenue
257
Cost of Revenue
121
Gross Profit
136
Gross Margin
52.9%
Operating Income
26
Operating Margin
9.9%
Net Income
8
Net Margin
3.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
29
EBITDA Margin
11.2%